06-May-15 China will lift price controls on most medicines starting from Jun-15, following which medicine prices will be decided by the market, the National Development & Reform Commission (NDRC) has said. Only narcotics and some listed psychotropic drugs will continue to be controlled by the government, with ceiling retail prices. [image: AFP Photo / Anthony Wallace]

06-May-15 Bayer HealthCare reaffirmed its strong position in China's healthcare industry with sales of EUR1.7 bn (USD1.9 bn) in 2014, 14% up on 2013. Its pharmaceuticals business grew at 15% in China, with a 26% spike in its consumer care business and 11% growth in its animal healthcare division. [image: China Daily]

30-Apr-15 Authorities in China's Xinjiang Uygur autonomous region plan to transform the area into a hub for international medical tourism and attract patients from across Central Asia. [image: China Daily]

30-Apr-15 Chinese Premier Li Keqiang has called for more medical reform measures to overcome difficulties in the healthcare system. Key areas include preventing hospitals being financed by drug sales, improvements in medical insurance payments, more private investment, and establishing a multi-tiered diagnosis and treatment system. [image: Xinhua Finance Agency]

27-Apr-15 Level 2 hospitals in China have been in relative decline and lost patients over recent years. Health service revenue from Level 2 hospitals increased by 14% on average from 2009 to 2013, compared with 19% in Level 1 hospitals and 24% in Level 3 hospitals. [image: Health Intelligence Asia]